The FDA’s Decision to Pause J&J Could Help Defeat Covid-19

No Thumbnail Available

Links to Files

https://www.wired.com/story/fda-decision-pause-jandj-could-help-defeat-covid/

Permanent Link

http://hdl.handle.net/11603/23516

Collections

UMBC School of Public Policy
UMBC Faculty Collection

Author/Creator

Author/Creator ORCID

https://orcid.org/0000-0003-2515-9731

Date

2021-04-16

Type of Work

articles
Text

Department

Program

Citation of Original Publication

McLaren, Zoe; The FDA’s Decision to Pause J&J Could Help Defeat Covid-19; Ideas, 16 April, 2021; https://www.wired.com/story/fda-decision-pause-jandj-could-help-defeat-covid/

Rights

This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.

Subjects

Johnson & Johnson’s Covid-19 vaccine
vaccine hesitancy
Food and Drug Administration

Abstract